Age-related Vulnerability and Its Impact on RSV Transmission Patterns and Population Immunization Effects - Report - MDSpire

Age-related Vulnerability and Its Impact on RSV Transmission Patterns and Population Immunization Effects

  • By

  • Chenkai Zhao

  • Yuhe Zhang

  • Richard Osei-Yeboah

  • Xiao Li

  • You Li

  • Xin Wang

  • Harish Nair

  • March 11, 2026

  • 0 min

Share

Clinical Report: Age-related Vulnerability and Its Impact on RSV Transmission Patterns

Overview

This report examines the age-dependent variations in susceptibility to respiratory syncytial virus (RSV) and their implications for transmission dynamics and immunization strategies. It highlights the significant burden of RSV on infants and older adults, emphasizing the need for targeted preventive measures.

Background

RSV is a major cause of lower respiratory tract infections, particularly affecting young children and older adults. The annual hospitalization rates for RSV show marked age-dependent variations, with infants under 6 months experiencing the highest rates. Understanding these variations is crucial for developing effective immunization strategies and reducing the overall disease burden.

Data Highlights

Remove placeholder text and replace with relevant data or a statement about data availability.

Key Findings

  • RSV hospitalization rates peak at 40–90 cases per 1000 infants under 6 months.
  • Infants and young children show increased susceptibility to RSV infections compared to older age groups.
  • Maternal vaccination with RSVpreF demonstrated 69% efficacy in reducing severe RSV infections in infants.
  • Nirsevimab has shown 82–90% effectiveness in preventing RSV-associated hospitalizations among children under 24 months.
  • Age-dependent susceptibility patterns significantly influence RSV transmission dynamics and population-level immunization effects.

Clinical Implications

Healthcare providers should prioritize immunization strategies targeting the most vulnerable age groups, particularly infants and older adults. Understanding age-related susceptibility can enhance the effectiveness of RSV prevention programs and reduce hospitalization rates.

Conclusion

Accurate characterization of age-dependent susceptibility to RSV is essential for optimizing immunization efforts and mitigating the impact of RSV on public health. Continued research and surveillance are necessary to refine these strategies.

References

  1. Open Forum Infectious Diseases, 2023 -- Evaluating the Risk of Respiratory Syncytial Virus in Adults: Considerations for Vaccine Guidelines Across Age Groups
  2. Open Forum Infectious Diseases, 2023 -- Limited Vaccination Rates and Health Disparities for Respiratory Syncytial Virus Among Veterans in the United States
  3. Open Forum Infectious Diseases, 2023 -- Normalization of Seasonality and Age Distribution of Pediatric RSV Infection Following the Pandemic Disruption in the Netherlands
  4. Open Forum Infectious Diseases, 2023 -- Association of Frailty with Clinical Outcomes in Hospitalized Older Adults Infected with Respiratory Syncytial Virus
  5. CDC, 2024 -- Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products
  6. CDC -- RSV Immunization Guidance for Infants and Young Children
  7. CDC -- RSV Hospitalization Rates and Immunization Strategies
  8. RSV Immunization Guidance for Infants and Young Children | RSV | CDC

Original Source(s)

Related Content